Alphatec Holdings, Inc. (NASDAQ:ATEC) announced preliminary financial results for Q4 and provided guidance for fiscal 2023 revenue and adjusted EBITDA. While numbers came in better than expected, shares fell more than 5% today.
For Q4, the company expects revenue to be in the range of $105.2-106.2 million (up 42-44% year-over-year), well above the Street estimate of $95.3 million. This includes Surgical revenue of $90.7-91.5 million (up 48-50% year-over-year), compared to the Street estimate of $83.5 million and EOS revenue of $14.5-14.7 million (up 13-15% year-over-year), compared to the Street estimate of $13.0 million.
For 2023, the company expects revenue to be $438 million (up 25% year-over-year), above the Street estimate of $412 million. Further, management reiterated expectations for reaching adjusted EBITDA breakeven in 2023.
At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com